Results 81 to 90 of about 87,830 (283)

The national and provincial prevalence and non-fatal burdens of diabetes in China from 2005 to 2023 with projections of prevalence to 2050

Military Medical Research
Background China accounts for one-quarter of the world’s diabetes population, with significant subnational disparities. However, none of the available data have provided comprehensive estimates and projections at both regional and national levels in ...
Yu-Chang Zhou, Jiang-Mei Liu, Zhen-Ping Zhao, Mai-Geng Zhou, Marie Ng   +4 more
doaj   +1 more source

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan, Lei Zhou, Jingzi ZhangBao, Hongmei Tan, Zhouzhou Wang, Chao Quan   +5 more
wiley   +1 more source

Analysis of the disease burden of vertebral fractures in China and worldwide from 1990 to 2021 and trend forecast to 2035

Journal of Health, Population and Nutrition
Methods Using the Global Burden of Disease (GBD) 2021 database, we analyzed the epidemiological trends of VFs in China from 1990 to 2021 and further explored the disease burden characteristics by age and sex.
Hongwen Gu, Kangen Han, Junchao Li, Zhihao Zhang, Le Xing, Yin Hu, Yanchun Xie, Hailong Yu   +7 more
doaj   +1 more source

From Comedy Targets to Comedy-Makers: Disability and Comedy in Live Performance [PDF]

, 2015
The stand-up comedy landscape has been transformed in recent years with an increased number of disabled comedians performing. Via semi-structured interviews with disabled comedians, this article provides a thematic analysis of the material and ...
Lockyer, S
core   +1 more source

Sertraline Treatment Can Mimic Niemann‐Pick Type C Biomarker Profile: A Diagnostic Pitfall

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Oxysterols (cholestane‐3β,5α,6β‐triol and 7‐ketocholesterol) and N‐palmitoyl‐O‐phosphocholineserine (PPCS) are sensitive biomarkers for Niemann‐Pick disease type C (NPC) screening. However, false‐positive results occur, with a biomarker profile suggestive of NPC despite the absence of pathogenic variants in genes involved in NPC or ...
Maria Makrygianni, Cecile Pagan, Antony Citterio‐Quentin, Isabelle Rouvet, Giulia Dingeo, Cyril Hanin, Claudine Laurent‐Levinson, Samia Pichard, Bénédicte Héron, Clément Gourguechon, Daniele Mandia, Jerome Guitton, Carole Lacout, Nicolas Schleinitz, Florient Potier, Olivier Flabeau, Elsa Besse‐Pinot, Foudil Lamari, Magali Pettazzoni, Yann Nadjar   +19 more
wiley   +1 more source

Additional file 2: of Temporal decomposition of life years lived with disability in India: a growing demographic concern

, 2019
Mortality and disability effect (ME and DE) from temporal decomposition of Change in Person Years Lived with Disability (CPYLD) in India and selected states in 2001- 2011.
Laxmi Dwivedi (7011974), Srei Chanda (7011971), Kajori Banerjee (7011968)   +2 more
core   +1 more source

Years lived with disability due to acute symptomatic COVID-19 infections in France in 2020 by age, sex and severity level.

, 2023
Years lived with disability due to acute symptomatic COVID-19 infections in France in 2020 by age, sex and severity level.
Panayotis Constantinou (3440513), Christophe Bonaldi (14498378), Romana Haneef (492329), Brecht Devleesschauwer (505283), Cécile Sommen (5954822), Antoine Rachas (197007), Myriam Fayad (14498375), Sara Monteiro Pires (12715619), Anne Fouillet (76891), Grant M. A. Wyper (5579336), Daniel Levy-Bruhl (5583653), Nathalie Beltzer (11536742), Anne Gallay (8959460)   +12 more
core   +1 more source

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin, Binbin Xue, Dewei Xie, Jia Li, Juyuan Pan, Lanbing Zhu, Qiaowen Tong, Jing Lin, Ruofan Zhu, Xu Zhang, Junhui Xia, Xiang Li   +11 more
wiley   +1 more source

Economic and disease burden of traumatic brain injury in the Netherlands (2010–2012). YLD: years lived with disability.

, 2014
Economic and disease burden of traumatic brain injury in the Netherlands (2010–2012). YLD: years lived with disability.
Juanita A. Haagsma (237271), Suzanne Polinder (360134), Annemieke C. Scholten (649069), Martien J. M. Panneman (347330), Ed F. van Beeck (347331)   +4 more
core   +1 more source

CAR T‐Cell Therapy in Neurology: A Scoping Review of Neuro‐Oncology, Autoimmune Diseases & Neurotoxicity

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy has been investigated in neurological diseases, encompassing both central nervous system malignancies and autoimmune disorders, thereby extending its application beyond hematological cancers.
Omar Alqaisi, Mohammed Dibas, Patricia Tai, Ala Dibas, Osama Souied, Suhair Al‐Ghabeesh   +5 more
wiley   +1 more source